PinnyPeptide

Semaglutide vs Survodutide

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Semaglutide

Weight Management

GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes.

Peptide B

Survodutide

Weight Management

Dual GLP-1 / glucagon receptor agonist in late-stage obesity trials.

Typical vial

3 mg

Typical dose

250-2400 mcg

Half-life

~7 days (168 hours)

FDA status

FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (…

Typical vial

10 mg

Typical dose

300-6000 mcg

Half-life

~80-90 hours (once-weekly dosing)

FDA status

Not FDA approved. Investigational compound in phase 3 clinic…

Semaglutide effects

  • Significant and sustained weight loss (15-17% body weight in trials)
  • Improved glycemic control and reduced HbA1c
  • Reduced appetite and food cravings through central satiety signaling
  • Cardiovascular risk reduction (20% MACE reduction in SELECT trial)
  • Slowed gastric emptying for prolonged satiety
  • Improved insulin sensitivity and beta-cell function

Survodutide effects

  • Substantial weight loss (~14-19% at highest doses in phase 2)
  • Suppresses appetite and slows gastric emptying via GLP-1
  • Increases energy expenditure via glucagon receptor activation
  • Reduces liver fat (notable MASH/NASH activity)
  • Improves glycemic control and fasting glucose
  • Lowers LDL cholesterol and triglycerides

Semaglutide side effects

  • Nausea (most common, especially during dose titration)
  • Vomiting and diarrhea
  • Constipation
  • Abdominal pain and dyspepsia
  • Pancreatitis (rare but serious)

Survodutide side effects

  • Nausea (most common, dose-dependent)
  • Vomiting
  • Diarrhea or constipation
  • Decreased appetite
  • Transient heart rate increase (5-10 bpm)
  • Injection site reactions
  • Mild fasting glucose elevation at low doses (resolves with titration)
  • Risk of gallbladder issues with rapid weight loss

Semaglutide dosing ranges

Type 2 diabetes (Ozempic)

250-1000 mcg · Once weekly (SubQ) · Ongoing as prescribed

Weight management (Wegovy)

2400 mcg · Once weekly (SubQ, after 16-week titration) · Ongoing as prescribed

Survodutide dosing ranges

Obesity (phase 2/3 protocol)

0.3-6.0 mg · Once weekly SubQ (titrated) · Long-term (chronic dosing)

MASH / NASH (phase 2)

1.2-6.0 mg · Once weekly SubQ (titrated) · 48 weeks minimum

Type 2 diabetes (phase 2)

0.3-4.8 mg · Once weekly SubQ · Long-term

Full Semaglutide guide → Full Survodutide guide →

Semaglutide vs Survodutide — common questions

What is the difference between Semaglutide and Survodutide?

Semaglutide: GLP-1 receptor agonist revolutionizing the treatment of obesity and type 2 diabetes. Typical dose 250-2400 mcg. Survodutide: Dual GLP-1 / glucagon receptor agonist in late-stage obesity trials. Typical dose 300-6000 mcg. Both fall under the Weight Management category.

Can you stack Semaglutide and Survodutide?

Stacking Semaglutide with Survodutide is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Semaglutide or Survodutide?

Semaglutide is typically dosed: Once weekly (SubQ) for Type 2 diabetes (Ozempic); Once weekly (SubQ, after 16-week titration) for Weight management (Wegovy). Survodutide is typically dosed: Once weekly SubQ (titrated) for Obesity (phase 2/3 protocol); Once weekly SubQ (titrated) for MASH / NASH (phase 2); Once weekly SubQ for Type 2 diabetes (phase 2).

Are Semaglutide and Survodutide FDA approved?

Semaglutide: FDA approved. Ozempic (2017) for type 2 diabetes, Rybelsus (2019) oral for diabetes, Wegovy (2021) for chronic weight management. Survodutide: Not FDA approved. Investigational compound in phase 3 clinical trials for obesity and MASH/NASH.

Related peptide comparisons

aod-9604 vs semaglutideftpp-adipotide vs semaglutidehgh-fragment-176-191 vs semaglutideretatrutide vs semaglutidesemaglutide vs tirzepatideaod-9604 vs survodutide

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free